Skip to main content

“Protein Crystallisation in space for Anti-Malaria Drug Development” project deliver a protein compound to the JAXA in Tsukuba City of Japan.

As part of the “Protein Crystallisation in space for Anti-Malaria Drug Development” project, the National Center for Genetic Engineering and Biotechnology (BIOTEC) and the Geo-Informatics Space Technology Development Agency (GISTDA) have jointly worked together to deliver a protein compound to the Japan Aerospace Exploration Agency (JAXA), located in Tsukuba City of Japan. The compound will be examined by JAXA before it will be transported to the International Space Station (ISS) under GISTDA’s “National Space Exploration” project (NSE), where it will crystalized under a weightless environment through the implementation of the KIBO experimental module from JAXA. The aim of the protein crystallisation is to develop efficient drugs against Malaria, as the process in space will allow the protein to be crystalised under an optimal environment, which should be more effective than the testings done on earth.

 

Share this article

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday